US Patent Issued to ADIMAB on Feb. 17 for "High affinity anti-CD3 antibodies, and methods for their generation and use" (New Hampshire Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,863, issued on Feb. 17, was assigned to ADIMAB LLC (Lebanon, N.H.).

"High affinity anti-CD3 antibodies, and methods for their generation and use" was invented by Robert Pejchal (Lebanon, N.H.), Caitlin Stein (Lebanon, N.H.) and Julia McCreary (Lebanon, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies and antigen-binding fragments thereof with high affinity for CD3 and desirable developability profiles are provided, as well as methods for their manufacture and use."

The patent was filed on June 8, 2020, under Application No. 17/617,046.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov...